Literature DB >> 18805448

Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1.

Amanda L Sheldon1, Marco I González, Elizabeth N Krizman-Genda, Bala T S Susarla, Michael B Robinson.   

Abstract

Sodium-dependent glutamate uptake is essential for limiting excitotoxicity, and dysregulation of this process has been implicated in a wide array of neurological disorders. The majority of forebrain glutamate uptake is mediated by the astroglial glutamate transporter, GLT-1. We and others have shown that this transporter undergoes endocytosis and degradation in response to activation of protein kinase C (PKC), however, the mechanisms involved remain unclear. In the current study, transfected C6 glioma cells or primary cortical cultures were used to show that PKC activation results in incorporation of ubiquitin into GLT-1 immunoprecipitates. Mutation of all 11 lysine residues in the amino and carboxyl-terminal domains to arginine (11R) abolished this signal. Selective mutation of the seven lysine residues in the carboxyl terminus (C7K-R) did not eliminate ubiquitination, but it completely blocked PKC-dependent internalization and degradation. Two families of variants of GLT-1 were prepared with various lysine residues mutated to arginine. Analyses of these constructs indicated that redundant lysine residues in the carboxyl terminus were sufficient for the appearance of ubiquitinated product and degradation of GLT-1. Together these data define a novel mechanism by which the predominant forebrain glutamate transporter can be rapidly targeted for degradation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805448      PMCID: PMC2629405          DOI: 10.1016/j.neuint.2008.07.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  79 in total

1.  What's Ub chain linkage got to do with it?

Authors:  Ikjin Kim; Hai Rao
Journal:  Sci STKE       Date:  2006-04-11

2.  Selective labeling of neurotransmitter transporters at the cell surface.

Authors:  G M Daniels; S G Amara
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

3.  Examination of glutamate transporter heterogeneity using synaptosomal preparations.

Authors:  M B Robinson
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

4.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

5.  Lysine 63 polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling.

Authors:  Thangiah Geetha; Jianxiong Jiang; Marie W Wooten
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

6.  Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase.

Authors:  K D Sims; D J Straff; M B Robinson
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

Review 7.  Expression patterns and regulation of glutamate transporters in the developing and adult nervous system.

Authors:  K D Sims; M B Robinson
Journal:  Crit Rev Neurobiol       Date:  1999

8.  Rapid trafficking of the neuronal glutamate transporter, EAAC1: evidence for distinct trafficking pathways differentially regulated by protein kinase C and platelet-derived growth factor.

Authors:  Keith M Fournier; Marco I González; Michael B Robinson
Journal:  J Biol Chem       Date:  2004-06-14       Impact factor: 5.157

9.  Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.

Authors:  Husam A J Alwan; Everardus J J van Zoelen; Jeroen E M van Leeuwen
Journal:  J Biol Chem       Date:  2003-06-26       Impact factor: 5.157

10.  The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch.

Authors:  Andrew Oberst; Martina Malatesta; Rami I Aqeilan; Mario Rossi; Paolo Salomoni; Rodolfo Murillas; Prashant Sharma; Michael R Kuehn; Moshe Oren; Carlo M Croce; Francesca Bernassola; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

View more
  32 in total

1.  Constitutive and regulated endocytosis of the glycine transporter GLYT1b is controlled by ubiquitination.

Authors:  Enrique Fernández-Sánchez; Jaime Martínez-Villarreal; Cecilio Giménez; Francisco Zafra
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

2.  Disruption of astrocytic glutamine turnover by manganese is mediated by the protein kinase C pathway.

Authors:  Marta Sidoryk-Wegrzynowicz; Eunsook Lee; Ni Mingwei; Michael Aschner
Journal:  Glia       Date:  2011-08-02       Impact factor: 7.452

Review 3.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

Review 4.  Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Y Lee
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

5.  Glutamate Transporters and Mitochondria: Signaling, Co-compartmentalization, Functional Coupling, and Future Directions.

Authors:  Michael B Robinson; Meredith L Lee; Sabrina DaSilva
Journal:  Neurochem Res       Date:  2020-01-30       Impact factor: 3.996

6.  Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal.

Authors:  Ronald Kim; Marian T Sepulveda-Orengo; Kati L Healey; Emily A Williams; Kathryn J Reissner
Journal:  Neuropharmacology       Date:  2017-09-14       Impact factor: 5.250

Review 7.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

8.  Mechanism of Mn(II)-mediated dysregulation of glutamine-glutamate cycle: focus on glutamate turnover.

Authors:  Marta Sidoryk-Wegrzynowicz; Eunsook Lee; Michael Aschner
Journal:  J Neurochem       Date:  2012-07-09       Impact factor: 5.372

9.  Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.

Authors:  Carmen Muñoz-Ballester; Arnaud Berthier; Rosa Viana; Pascual Sanz
Journal:  Biochim Biophys Acta       Date:  2016-03-11

10.  Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy.

Authors:  Xueqin Wang; Longze Sha; Nannan Sun; Yan Shen; Qi Xu
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.